The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome

• Main Authors: Ampaiwan Chuansumrit, Kanchana Tangnararatchakit, Yujinda Lektakul, Viroj Pongthanapisith, Nuntaporn Nimjaroenniyom, Pattra Thanarattanakorn, Malai Wongchanchailert, Patcharee Komwilaisak
• Other Authors: Department of Pediatrics
• Format: Article
• Published: 2018
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/21652
• Institution: Mahidol University

To report the use of recombinant activated factor VII (rFVIIa) in controlling life-threatening bleeding episodes in patients with grades III and IV Dengue Hemorrhagic Fever (DHF), also known as Dengue Shock Syndrome. Fifteen patients (seven boys, eight girls), whose median age was 8 years, were enro...